trending Market Intelligence /marketintelligence/en/news-insights/trending/DR4oyLkJE1w4BeZqzIG0FQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Biotechnology company Inscripta raises $125M in series D round

Street Talk Episode 56 - Latest bank MOE shows even the strong need scale to thrive

South State CenterState MOE Shows Even The Strong Need Scale To Thrive

Talking Bank Stocks, Playing The M&A Trade With Longtime Investor

Report: Kashkari Says Fed In Holding Pattern But Rate Cut Still Possible

Biotechnology company Inscripta raises $125M in series D round

Inscripta Inc. raised $125 million in its series D funding round, which was led by Paladin Capital Group.

New investors JS Capital Management LLC and Oak HC/FT Partners LLC participated in the round, alongside existing investors.

Inscripta has now raised a total of $259.5 million.

Inscripta is a Boulder, Colo.-based biotechnology company that is developing a benchtop platform for genome-scale engineering.